Novo Nordisk shares sink after Alzheimer’s drug trial fails | REUTERS



This content originally appeared on Reuters and was authored by Reuters


This content originally appeared on Reuters and was authored by Reuters


Print Share Comment Cite Upload Translate Updates
APA

Reuters | Sciencx (2025-11-24T16:13:48+00:00) Novo Nordisk shares sink after Alzheimer’s drug trial fails | REUTERS. Retrieved from https://www.scien.cx/2025/11/24/novo-nordisk-shares-sink-after-alzheimers-drug-trial-fails-reuters/

MLA
" » Novo Nordisk shares sink after Alzheimer’s drug trial fails | REUTERS." Reuters | Sciencx - Monday November 24, 2025, https://www.scien.cx/2025/11/24/novo-nordisk-shares-sink-after-alzheimers-drug-trial-fails-reuters/
HARVARD
Reuters | Sciencx Monday November 24, 2025 » Novo Nordisk shares sink after Alzheimer’s drug trial fails | REUTERS., viewed ,<https://www.scien.cx/2025/11/24/novo-nordisk-shares-sink-after-alzheimers-drug-trial-fails-reuters/>
VANCOUVER
Reuters | Sciencx - » Novo Nordisk shares sink after Alzheimer’s drug trial fails | REUTERS. [Internet]. [Accessed ]. Available from: https://www.scien.cx/2025/11/24/novo-nordisk-shares-sink-after-alzheimers-drug-trial-fails-reuters/
CHICAGO
" » Novo Nordisk shares sink after Alzheimer’s drug trial fails | REUTERS." Reuters | Sciencx - Accessed . https://www.scien.cx/2025/11/24/novo-nordisk-shares-sink-after-alzheimers-drug-trial-fails-reuters/
IEEE
" » Novo Nordisk shares sink after Alzheimer’s drug trial fails | REUTERS." Reuters | Sciencx [Online]. Available: https://www.scien.cx/2025/11/24/novo-nordisk-shares-sink-after-alzheimers-drug-trial-fails-reuters/. [Accessed: ]
rf:citation
» Novo Nordisk shares sink after Alzheimer’s drug trial fails | REUTERS | Reuters | Sciencx | https://www.scien.cx/2025/11/24/novo-nordisk-shares-sink-after-alzheimers-drug-trial-fails-reuters/ |

Please log in to upload a file.




There are no updates yet.
Click the Upload button above to add an update.

You must be logged in to translate posts. Please log in or register.